TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biozone Scientific Scandinavia AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
5,025
|
5,456
|
5,474 |
Financial expenses |
15
|
31
|
18 |
Earnings before taxes |
34
|
110
|
-68 |
EBITDA |
22
|
130
|
-51 |
Total assets |
1,082
|
1,715
|
2,024 |
Current assets |
1,082
|
1,715
|
2,024 |
Current liabilities |
366
|
753
|
880 |
Equity capital |
716
|
962
|
1,144 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
66.2%
|
56.1%
|
56.5% |
Turnover per employee |
2,512
|
2,728
|
2,737 |
Profit as a percentage of turnover |
0.7%
|
2.0%
|
-1.2% |
Return on assets (ROA) |
4.5%
|
8.2%
|
-2.5% |
Current ratio |
295.6%
|
227.8%
|
230.0% |
Return on equity (ROE) |
4.7%
|
11.4%
|
-5.9% |
Change turnover |
-431
|
-18
|
-1,620 |
Change turnover % |
-8%
|
0%
|
-23% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.